Rafael Martínez Leal

Mr. Rafael Martínez Leal


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2011 in World Psychiatry
Verified
Journal Article
Open access
PDF file
LSLuis Salvador-Carulla
Luis Salvador-Carulla
GRGeoffrey M. Reed
Geoffrey M. Reed
LVLeila M. Vaez‐Azizi
Leila M. Vaez‐Azizi
SCSally-Ann Cooper
Sally-Ann Cooper
RLRafael Martínez Leal
Rafael Martínez Leal
SSShekhar Saxena
Shekhar Saxena
Click on the article title to read more.

1 November 2007 in The British Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
SPStefan Priebe
Stefan Priebe
RMRosemarie McCabe
Rosemarie McCabe
JBJens Bullenkamp
Jens Bullenkamp
LHLars Hansson
Lars Hansson
CLChristoph Lauber
Christoph Lauber
DWDonna J. Wright
Donna J. Wright
Background: Patient–clinician communication is central to mental healthcare but neglected in research.Aims: To test a new computer-mediated intervention structuring patient–clinician dialogue (DIALOG) focusing on patients' quality of life and needs for care.Method: In a cluster randomised controlled trial, 134 keyworkers in six countries were allocated to DIALOG or treatment as usual; 507 people with schizophrenia or related disorders were included. Every 2 months for 1 year, clinicians asked patients to rate satisfaction with quality of life and treatment, and request additional or different support. Responses were fed back immediately in screen displays, compared with previous ratings and discussed. Primary outcome was subjective quality of life, and secondary outcomes were unmet needs and treatment satisfaction.Results: Of 507 patients, 56 were lost to follow-up and 451 were included in intention-to-treat analyses. Patients receiving the DIALOG intervention had better subjective quality of life, fewer unmet needs and higher treatment satisfaction after 12 months.Conclusions: Structuring patient–clinician dialogue to focus on patients' views positively influenced quality of life, needs for care and treatment satisfaction.

27 April 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RMRose McCabe
Rose McCabe
JBJens Bullenkamp
Jens Bullenkamp
LHLars Hansson
Lars Hansson
CLChristoph Lauber
Christoph Lauber
RLRafael Martínez Leal
Rafael Martínez Leal
SPStefan Priebe
Stefan Priebe
Previous research has shown that a better therapeutic relationship (TR) predicts more positive attitudes towards antipsychotic medication, but did not address whether it is also linked with actual adherence. This study investigated whether the TR is associated with adherence to antipsychotics in patients with schizophrenia. 134 clinicians and 507 of their patients with schizophrenia or a related psychotic disorder participated in a European multi-centre study. A logistic regression model examined how the TR as rated by patients and by clinicians is associated with medication adherence, adjusting for clinician clustering and symptom severity. Patient and clinician ratings of the TR were weakly inter-correlated (rs = 0.13, p = 0.004), but each was independently linked with better adherence. After adjusting for patient rated TR and symptom severity, each unit increase in clinician rated TR was associated with an increase of the odds ratio of good compliance by 65.9% (95% CI: 34.6% to 104.5%). After adjusting for clinician rated TR and symptom severity, for each unit increase in patient rated TR the odds ratio of good compliance was increased by 20.8% (95% CI: 4.4% to 39.8%). A better TR is associated with better adherence to medication among patients with schizophrenia. Patients' and clinicians' perspectives of the TR are both important, but may reflect distinct aspects.

11 January 2018 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
AVAlba Valiente-Pallejà
Alba Valiente-Pallejà
Helena TorrellHelena Torrell
Helena Torrell
GMGerard Muntane
Gerard Muntane
MCMaria J Cortés
Maria J Cortés
RLRafael Martínez Leal
Rafael Martínez Leal
Lourdes MartorellLourdes Martorell
Lourdes Martorell
Clinical conditions commonly associated with mitochondrial disorders (CAMDs) are often present in autism spectrum disorders (ASD) and intellectual disability (ID). Therefore, the mitochondrial dysfunction hypothesis has been proposed as a transversal mechanism that may function in both disorders. Here, we investigated the presence of conditions associated with mitochondrial disorders and mitochondrial DNA (mtDNA) alterations in 122 subjects who presented ASD with ID (ASD group), 115 subjects who presented ID but not ASD (ID group) and 112 healthy controls (HC group). We assessed in the three study groups the presence of the clinical conditions through a questionnaire and the mtDNA content of two mitochondrial genes, MT-ND1 and MT-ND4, by qPCR. The mtDNA sequences of 98 ASD and 95 ID subjects were obtained by mtDNA-targeted next generation sequencing and analysed through the MToolBox pipeline to identify mtDNA mutations. Subjects with ASD and ID showed higher frequencies of constipation, edema, seizures, vision alterations, strabismus and sphincter incontinence than HCs subjects. ASD and ID subjects showed significantly lower mtDNA content than HCs in both MT-ND1 and MT-ND4 genes. In addition, we identified 49 putative pathogenic variants with a heteroplasmy level higher than 60%: 8 missense, 29 rRNA and 12 tRNA variants. A total of 28.6% of ASD and 30.5% of ID subjects carried at least one putative pathogenic mtDNA mutation. The high frequency of CAMDs, the low mtDNA content and the presence of putative pathogenic mtDNA mutations observed in both ASD and ID subjects are evidence of mitochondrial dysfunction in ASD and ID.

1 April 2013 in Psychiatric Genetics
Verified
Journal Article
Closed access
Claudio TomaClaudio Toma
Claudio Toma
AHAmaia Hervás
Amaia Hervás
BTBàrbara Torrico
Bàrbara Torrico
NBNoemí Balmaña
Noemí Balmaña
MSMarta Salgado
Marta Salgado
BCBru Cormand
Bru Cormand
Impairment of language abilities is a common feature in autistic individuals. Heterozygous mutations in the Forkhead Box P2 (FOXP2) gene lead to a severe spoken language disorder. Recently, several studies have pinpointed the involvement of common variants of the Contactin-Associated Protein-Like 2 (CNTNAP2) gene, whose transcription is regulated by the product of FOXP2, in several disorders characterized by language impairments such as autism, specific language impairment (SLI), and selective mutism (SM). In the present study, common variants of the FOXP2 and the CNTNAP2 genes were analyzed through a case–control association study in 322 Spanish autistic patients and 524 controls. The results of this study suggest that common variants of FOXP2 are unlikely to contribute to autism susceptibility, in agreement with previous findings. Furthermore, we failed to replicate in our sample a previous association finding of two single nucleotide polymorphisms (rs2710102 and rs7794745) in the CNTNAP2 gene with autism. No evidence for the association of these genes with language traits was observed in our analysis.

1 July 2013 in Revista de Psiquiatría y Salud Mental
Verified
Journal Article
Closed access
LSLuis Salvador-Carulla
Luis Salvador-Carulla
JGJuan Carlos García-Gutiérrez
Juan Carlos García-Gutiérrez
Mencía R. Gutiérrez-ColosíaMencía R. Gutiérrez-Colosía
Mencía R. Gutiérrez-Colosía
JAJosep Artigas-Pallarès
Josep Artigas-Pallarès
JIJosé García Ibáñez
José García Ibáñez
RLRafael Martínez Leal
Rafael Martínez Leal